Bionano Genomics, Inc.
BNGO • NASDAQ • Stock Fundamentals
Bionano Genomics, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Robert Erik Holmlin, with a market cap of $14.0M.
Market Cap$14.0M
Employees344.0
CEORobert Erik Holmlin
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Bionano Genomics, Inc. FAQ
Common questions about Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) has a market capitalization of $14.0M and trades on NASDAQ.
Bionano Genomics, Inc. has approximately 344 employees.